News

What do we really know about the long-term use of Ozempic and Mounjaro?
As more people resort to a new generation of drugs to achieve the perfect body, Leah Hardy examines the latest warnings over ...
NVO Stock Gains After Parvus Asset Management Builds Stake
Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...
Fierce Pharma4d
TV drug ad spending continued downward slope in May, with AbbVie’s Skyrizi hanging on to top spot
Novo Nordisk slashed its spending on TV ads for Wegovy by almost 24% between April and May, from $31.6 million to $24.1 ...
Risks with Ozempic: A look at an alternative to weight-loss drugs - opinion
Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...
Business Wire5d
Sylvan Receives Investment from Novo Holdings to Drive Further Growth
BEIJING--(BUSINESS WIRE)--Novo Holdings, a leading global life science investor, and KKR, a leading global investment firm, today announced the signing of definitive agreements under which Novo ...
Devdiscourse6d
Health News: Measles Outbreak Status, Omada IPO Surge, and More
Recent health updates include Texas experiencing a lull in measles cases, Omada’s successful Nasdaq debut, no bird flu ...